Financhill
Back

Revance Therapeutics Stock Price Chart

  • The current trend is moderately bearish and RVNC is experiencing selling pressure, which indicates risk of future bearish movement.

Revance Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 6.35 Sell
20-day SMA: 6.49 Sell
50-day SMA: 5.16 Buy
200-day SMA: 5.05 Buy
8-day EMA: 6.25 Sell
20-day EMA: 6.21 Sell
50-day EMA: 5.42 Buy
200-day EMA: 6.59 Sell

Revance Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.25 Buy
Relative Strength Index (14 RSI): 48.82 Sell
Chaikin Money Flow: -2917555 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.31 - 6.71) Sell
Bollinger Bands (100): (2.57 - 5.65) Buy

Revance Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Revance Therapeutics Stock

Is Revance Therapeutics Stock a Buy?

RVNC Technical Analysis vs Fundamental Analysis

Sell
21
Revance Therapeutics (RVNC) is a Sell

Is Revance Therapeutics a Buy or a Sell?

Revance Therapeutics Stock Info

Market Cap:
624.04M
Price in USD:
5.99
Share Volume:
5.5M

Revance Therapeutics 52-Week Range

52-Week High:
14.24
52-Week Low:
2.30
Sell
21
Revance Therapeutics (RVNC) is a Sell

Revance Therapeutics Share Price Forecast

Is Revance Therapeutics Stock a Buy?

Fundamental Analysis of Revance Therapeutics

Is Revance Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.54 per share, an increase next quarter of $0.40 per share, an increase this year of $2.64 per share, and an increase next year of $0.70 per share.

Technical Analysis of Revance Therapeutics

Should I short Revance Therapeutics stock?

* Revance Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.